ReviewDermatology practical & conceptual2026
Epidemiology and Clinical Characteristics of Harlequin Ichthyosis: A Systematic Review and Meta-Analysis of Case Reports.
Review in Dermatology practical & conceptual, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHarlequin ichthyosis (HI) is considered one of the rarest and most severe congenital disorders, characterized by the development of thick, plate-like scales, ectropion, eclabium, and multi-system complications that mainly cause high neonatal mortality.
objectivesThis systematic review and meta-analysis aimed to comprehensively summarize all reported global case reports and series of harlequin ichthyosis, identifying common clinical presentations and geographic and genetic trends, and evaluating outcomes of different treatment approaches to inform better management strategies for this rare disease.
methodsA comprehensive search across different databases using different predefined terms was conducted; only case reports and case series in English were included in this review.
resultsThe review was conducted among 56 case studies and case series, including 68 cases that revealed that 64.7% had an unspecified genetic mutation, while 30.9 % carried an ABCA12 mutation. The clinical manifestations among the patients were severe, including thick scales, reported in 79.4% of the patients, ectropion, reported in 80.9% of them, and eclabium, which was reported in 79.4% of the patients. Despite the supportive care received by the patients, the mortality rate was as high as 60.3%, with an average age at death of 47.19 days. Treatment response varied among the patients, with only 30.9% of them showing clinical improvement.
conclusionOur review highlights the significantly high morbidity and mortality rates associated with a diagnosis of HI, indicating the need for early diagnosis, genetic counseling, and improvement in the management strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.